Application
Fig1: Western blot analysis of CBL on human CBL recombinant protein using anti-CBL antibody at 1/1,000 dilution.
Application
Fig2: Western blot analysis of CBL on different cell lysates using anti-CBL antibody at 1/1,000 dilution.
Positive control:
Lane 1: RAJI
Lane 2: RAW264.7
Lane 3: K562
Lane 4: SKBR-3
Lane 5: 3T3-L1
Lane 6: THP-1
Lane 7: PC-12
Application
Fig3: ICC staining CBL (green) and actin filaments (red) in Hela cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Application
Fig4: Immunohistochemical analysis of paraffin-embedded ovarian cancer tissue using anti-CBL antibody. Counter stained with hematoxylin.
Application
Fig5: Immunohistochemical analysis of paraffin-embedded bladder cancer tissue using anti-CBL antibody. Counter stained with hematoxylin.
Application
Fig6: Flow cytometric analysis of MCF-7 cells with CBL antibody at 1/100 dilution (blue) compared with an unlabelled control (cells without incubation with primary antibody; red).